Acne Vulgaris - Pipeline Review, H2 2012 New Report
Acne Vulgaris - Pipeline Review, H2 2012, provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. 'Acne Vulgaris - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release